Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00134186
Recruitment Status : Completed
First Posted : August 24, 2005
Last Update Posted : March 5, 2007
Information provided by:
Pharmacyclics LLC.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : No date given